Vivo Bio Tech Limited (VIVOBIOT.BO)

INR 36.76

(-0.03%)

Operating Expenses Summary of Vivo Bio Tech Limited

Vivo Bio Tech Limited's latest annual operating expenses in 2023 was 57.03 Million INR , down -10.3% from previous year.
Vivo Bio Tech Limited's latest quarterly operating expenses in 2024 Q1 was 17.5 Million INR , down -77.57% from previous quarter.
Vivo Bio Tech Limited reported a annual operating expenses of 332.24 Million INR in annual operating expenses 2022, up 5.19% from previous year.
Vivo Bio Tech Limited reported a annual operating expenses of 315.85 Million INR in annual operating expenses 2021, down -2.44% from previous year.
Vivo Bio Tech Limited reported a quarterly operating expenses of 76.27 Million INR for 2023 Q1, down -11.49% from previous quarter.
Vivo Bio Tech Limited reported a quarterly operating expenses of 78 Million INR for 2023 Q4, up 0.42% from previous quarter.

Annual Operating Expenses Chart of Vivo Bio Tech Limited (2023 - 2019)

Historical Annual Operating Expenses of Vivo Bio Tech Limited (2023 - 2019)

Year	Operating Expenses	Operating Expenses Growth
2023	57.03 Million INR	-10.3%
2022	332.24 Million INR	5.19%
2021	315.85 Million INR	-2.44%
2020	323.76 Million INR	3.47%
2019	312.89 Million INR	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	17.5 Million INR	-77.57%
2023 Q1	76.27 Million INR	-11.49%
2023 Q4	78 Million INR	0.42%
2023 Q3	77.68 Million INR	17.6%
2023 FY	298.02 Million INR	-10.3%
2023 Q2	66.05 Million INR	-13.4%
2022 FY	332.24 Million INR	5.19%
2022 Q4	86.17 Million INR	4.54%
2022 Q3	82.43 Million INR	-1.49%
2022 Q1	79.95 Million INR	-12.28%
2022 Q2	83.67 Million INR	4.66%
2021 Q2	75.89 Million INR	11.01%
2021 Q1	68.36 Million INR	-42.79%
2021 Q3	76.71 Million INR	1.09%
2021 Q4	91.13 Million INR	18.8%
2021 FY	315.85 Million INR	-2.44%
2020 Q3	60.11 Million INR	-33.36%
2020 Q2	90.2 Million INR	67.25%
2020 Q1	53.93 Million INR	1342.11%
2020 FY	323.76 Million INR	3.47%
2020 Q4	119.5 Million INR	98.79%
2019 Q4	3.74 Million INR	-96.22%
2019 FY	312.89 Million INR	0.0%
2019 Q3	98.84 Million INR	19.36%
2019 Q1	97.48 Million INR	48.39%
2019 Q2	82.81 Million INR	-15.05%
2018 Q4	65.69 Million INR	-32.76%
2018 Q1	- INR	-100.0%
2018 Q2	83.85 Million INR	0.0%
2018 Q3	97.7 Million INR	16.52%
2017 Q1	91.06 Million INR	52.6%
2017 Q4	64.27 Million INR	-18.72%
2017 Q3	79.08 Million INR	2.04%
2017 Q2	77.5 Million INR	-14.89%
2016 Q1	45.31 Million INR	-32.13%
2016 Q4	59.67 Million INR	10.54%
2016 Q3	53.98 Million INR	-15.1%
2016 Q2	63.58 Million INR	40.33%
2015 Q3	33.19 Million INR	-41.62%
2015 Q4	66.76 Million INR	101.16%
2015 Q1	37.5 Million INR	-27.28%
2015 Q2	56.84 Million INR	51.59%
2014 Q4	51.56 Million INR	39.98%
2014 Q1	32.11 Million INR	-13.27%
2014 Q2	23.67 Million INR	-26.29%
2014 Q3	36.84 Million INR	55.62%
2013 Q4	37.02 Million INR	0.0%

Peer Operating Expenses Comparison of Vivo Bio Tech Limited

Name	Operating Expenses	Operating Expenses Difference
Chandra Bhagat Pharma Limited	30.37 Million INR	-87.798%
Checkpoint Trends Limited	5.02 Million INR	-1034.846%
Everest Organics Limited	122.26 Million INR	53.35%
GUJARAT INJECT (KERALA) LTD.	3.85 Million INR	-1380.245%
NATURO INDIABULL LIMITED	3.71 Million INR	-1436.53%
NEXUS SURGICAL AND MEDICARE LI	23.45 Million INR	-143.128%
Rajnish Wellness Limited	14.94 Million INR	-281.69%
Rama Vision Limited	88.37 Million INR	35.461%